Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn

被引:23
|
作者
Rovedo, Mark [1 ]
Longnecker, Richard [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA
关键词
D O I
10.1128/JVI.00843-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Latent membrane protein 2A (LMP2A) is a viral protein expressed during Epstein-Barr virus (EBV) latency in EBV-infected B cells both in cell culture and in vivo. LMP2A has important roles in modulating B-cell receptor signal transduction and provides survival and developmental signals to B cells in vivo. Although Lyn has been shown to be important in mediating LMP2A signaling, it is still unclear if Lyn is used preferentially or if LMP2A associates promiscuously with other Sire family kinase (SFK) members. To investigate the role of various SFKs in LMP2A signaling, we crossed LMP2A transgenic mice (TgE) with Lyn(-/-), Fyn(-/-), or Blk(-/-) mice. TgE Lyn(-)/(-)mice had a larger immunoglobulin M (IgM)-positive B-cell population than TgE mice, suggesting that the absence of Lyn prevents LMP2A from delivering survival and developmental signals to the B cells. Both TgE Fyn(-/-)and TgE Blk(-/-)mice have an IgM-negative population of splenic B cells, similar to the TgE mice. LMP2A was also transiently transfected into the human EBV-negative B-cell line BJAB to determine which SFK members associate with LMP2A. Lyn was detected in LMP2A immunoprecipitates, whereas Fyn was not. Both Lyn and Fyn were able to bind to an LMP2A mutant which contained a sequence shown previously to bind tightly to the SH2 domain of multiple SFK members. From these results, we conclude that LMP2A preferentially associates with and signals through Lyn compared to its association with other FKs. This preferential association is due in part to the SH2 domain of Lyn associating with LMP2A.
引用
收藏
页码:8520 / 8528
页数:9
相关论文
共 50 条
  • [31] The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer
    Pang, Mei-Fong
    Lin, Kah-Wai
    Peh, Suat-Cheng
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2009, 14 (02) : 222 - 247
  • [32] In Silico Modeling and Characterization of Epstein-Barr Virus Latent Membrane Protein 1 Protein
    Salam, Dayang-Sharyati D. A.
    Gunasinghe, Kavinda Kashi Juliyan
    Hwang, Siaw San
    Ginjom, Irine Runnie Henry
    Wezen, Xavier Chee
    Rahman, Taufiq
    ACS OMEGA, 2024, 9 (50): : 49422 - 49431
  • [33] Role of Epstein-Barr virus gene latent membrane protein in nasopharyngeal carcinoma
    Nicholson, LJ
    Morris, JDH
    TRENDS IN MICROBIOLOGY, 1996, 4 (04) : 132 - 133
  • [34] The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor
    Ingham, RJ
    Raaijmakers, J
    Lim, CSH
    Mbamalu, G
    Gish, G
    Chen, F
    Matskova, L
    Enrberg, I
    Winberg, G
    Pawson, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (40) : 34133 - 34142
  • [35] Modulation of Epstein-Barr virus latent membrane protein 1 activity by intrabodies
    Fang, Chih Yeu
    Chiang, Chen Yi
    Pan, Yun Ru
    Tse, Ka Po
    Chang, Yu Sun
    Chang, Hwan You
    INTERVIROLOGY, 2007, 50 (04) : 254 - 263
  • [36] Protein Kinase CK2 and Epstein-Barr Virus
    Montenarh, Mathias
    Graesser, Friedrich A.
    Goetz, Claudia
    BIOMEDICINES, 2023, 11 (02)
  • [38] Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis
    Niedobitek, G
    Kremmer, E
    Herbst, H
    Whitehead, L
    Dawson, CW
    Niedobitek, E
    vonOstau, C
    Rooney, N
    Grasser, FA
    Young, LS
    BLOOD, 1997, 90 (04) : 1664 - 1672
  • [39] Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia
    Longan, L
    Longnecker, R
    JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 2245 - 2252
  • [40] Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies
    CHEN Yun YAO Kun SUN Hua QING Jian and PENG Guangyong Department of Microbiology and Immunology Nanjing Medical University Nanjing China College of English Hehai University Nanjing China Center for Cell and Gene Therapy Baylor College of Medicine Houston Texas USA
    ChineseMedicalJournal, 2005, (09) : 725 - 730